Concepedia

Changgui Li

CL

Statistics

Publications

79

Citations

8.1K

H-Index

36

Active since

2006

Affiliations

National Institutes for Food and Drug Control(Current)

Health Canada

Chinese Academy of Medical Sciences & Peking Union Medical College

Sinovac Biotech

University of Ottawa

Changgui Li is an author at National Institutes for Food and Drug Control specializing in infectious diseases, immunology, and vaccination.

ORCID

Publications per year

2006–2023

79

Publications

79

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

, , +15

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang, Yuntao Zhang, Baoying Huang et al. · Cell · 2020 · 801 citations · Full text

, , +14

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Shilong Yang, Yan Li, Lianpan Dai et al. · The Lancet Infectious Diseases · 2021 · 454 citations · Full text

, , +10

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Bihua Han, Yufei Song, Changgui Li et al. · The Lancet Infectious Diseases · 2021 · 355 citations · Full text

, , +16

1–5 of 79